S100A2 and non-small cell lung carcinoma: Conversely, in addition to our analysis of NSCLC, over-representation of S100A2 has also been reported in gastric cancer (El-Rifai et al, 2002) ovarian cancer (Hough et al, 2001) and head and neck cancer (Villaret et al, 2000).